281 related articles for article (PubMed ID: 9156042)
1. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
[TBL] [Abstract][Full Text] [Related]
2. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
3. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
[TBL] [Abstract][Full Text] [Related]
4. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
[TBL] [Abstract][Full Text] [Related]
6. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
[TBL] [Abstract][Full Text] [Related]
7. Comparison between pituitary computed tomographic findings and tests of hypothalamo-pituitary function in 72 patients with hyperprolactinaemia.
Ghigo E; Ciccarelli E; Bianchi SD; Gatti G; Molinatti GM; Massara F; Müller EE; Camanni F
Acta Endocrinol (Copenh); 1986 May; 112(1):20-7. PubMed ID: 3087130
[TBL] [Abstract][Full Text] [Related]
8. Tumoral versus non-tumoral hyperprolactinemia in children and adolescents: possible usefulness of the domperidone test.
Fideleff HL; Azaretzky M; Boquete HR; Pujol AB; Honfi M; Suárez MG; Fideleff G; Giaccio AV
J Pediatr Endocrinol Metab; 2003 Feb; 16(2):163-7. PubMed ID: 12713252
[TBL] [Abstract][Full Text] [Related]
9. Screening for macroprolactinaemia and pituitary imaging studies.
Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
Ciccarelli E; Ghigo E; Miola C; Gandini G; Muller EE; Camanni F
Clin Endocrinol (Oxf); 1990 May; 32(5):583-92. PubMed ID: 2114241
[TBL] [Abstract][Full Text] [Related]
11. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
12. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.
Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS
Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629
[TBL] [Abstract][Full Text] [Related]
13. The inability of dynamic tests of prolactin and TSH secretion to differentiate between tumorous and non-tumorous hyperprolactinemia.
Prescott RW; Johnston DG; Taylor PK; Haigh J; Weightman DR; Hall K; Cook DB
J Endocrinol Invest; 1985 Feb; 8(1):49-54. PubMed ID: 3921596
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
16. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma.
Brismar K; Hulting AL; Werner S
J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920
[TBL] [Abstract][Full Text] [Related]
17. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
18. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
20. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.
Ghigo E; Pogliano G; Campagnoli C; Bertagna A; Camanni F; Massara F
J Endocrinol Invest; 1984 Oct; 7(5):525-7. PubMed ID: 6439773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
